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SUMMARY
Objective: To identify what information is provided to patients by oncologists, assess 
what they take into account in the process of informing the patient, and to ascertain 
whom the information is provided to. Methods: The study subjects were oncologists re-
cruited among those registered at the Brazilian Society of Clinical Oncology – SBOC. All 
material was mailed to the Society, which was then forwarded to the participant oncolo-
gists. The previously stamped envelopes contained: a questionnaire, the questionnaire 
instructions, and  the informed consent form to be signed. The data obtained was sta-
tistically treated, following a 95% confidence interval. Results: 876 questionnaires were 
sent (total number of physicians registered at SBOC) and a 16.55% response rate was 
achieved. Regarding the information provided, 81% of the physicians responded they 
informed patients about diagnosis, treatment and prognosis; however, 73% reported that 
in most cases the patient is already aware of his/her disease. Nevertheless, the informa-
tion is provided to the patient and his(her) family by 81% of doctors. Among the relevant 
aspects in the information process, the patient’s gender has little influence on the infor-
mation for 95% of doctors. Conclusion: Considering the results achieved, we conclude 
that in the study population, physicians are concerned about providing information ac-
cording to the patient’s profile. We could also notice that oncologists try to provide pa-
tients with the information they are entitled to — the truth, although they often resort to 
the family’s assistance in providing that information.
Keywords: Personal autonomy; physician-patient relations; disclosure; bioethics.
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INTRODUCTION
Over the years, the physician-patient relationship has been 
guided mainly by charity and non-detraction principles. 
Specifically in Brazil, this relationship has been built under 
a patronizing and conservative model1. A new behavior 
was adopted by physicians in view of the patients’ eman-
cipation and the formulation of their rights, especially the 
right to self-determination. This change also created new 
ethical conflicts, which can be more frequently seen in cer-
tain specialties, such as Oncology. Cancer is still known 
as a stigmatizing disease in people’s minds, in spite of all 
advances reached and, for a number of physicians, cancer 
diagnosis might be related to death, and this could inter-
fere with the clinical management2.
Informing the patient is a doctor’s obligation and a 
required condition so that autonomy is exerted; however, 
this obligation must be fulfilled by observing several as-
pects, including the humanitarian ones. In the case of dis-
closing a cancer diagnosis, depending on how the doctor 
communicates the diagnosis, this could lead to an inter-
ference on the patient’s relationship with his/her own dis-
ease3. From the informed consent, physicians have a legal 
and ethical obligation to inform the patient about risks, 
benefits or available treatment options4 and either about 
palliative care availability as required.
Palliative care is considered an approach that improves 
patients’ and family’s quality of life in the face of a terminal 
illness with suering prevention and relief through early 
identification, strict evaluation, and pain and other physical, 
psychosocial, and spiritual problems5. Palliative care goes 
beyond the traditional care model, as it advocates patient 
care should be whole in all health aspects6.
The di cult task of disclosing the diagnosis can be dif-
ferent, depending on each physician’s individual experience, 
and the physician should be prepared to act in an eective 
way, taking into account the patient’s cultural, social and 
psychological issues regarding the information preferences3. 
In a survey addressing the patient’s rights in an information 
and autonomy setting, the subjects – patients with cancer – 
reported they agreed the patient is entitled to be informed 
(86.5%)7. The cautious physician should evaluate each case 
and think thourougly on the available alternatives for ac-
tion: telling the patient the whole truth, partially telling the 
truth, not telling the truth or leaving some information out. 
In his/her appreciation, the physician should take into ac-
count that only a morally relevant fact, in terms of charity or 
non-detraction, could warrant a patronizing action, ignor-
ing the patient’s right to know the truth and consequently to 
define his/her treatment limits8.
In situations where there is a conflict between the char-
ity and autonomy principles, some physicians believe the 
obligation to do good superposes respecting the patient’s 
will – the autonomy principle9. The physician must consider 
each situation and try to recognize the interests that might 
be behind the decisions, how these decisions will interfere 
with the patient’s life and what the patients really want10.
In view of the ethical conflict arising, this study aimed 
to identify: what kind of information oncologists convey to 
their patients; what they take into account in the informa-
tion process; and whom they provide information to, all 
this according to oncologists themselves.
METHODS
The research project that generated this study was de-
signed in accordance with the ethical recommendations 
contained in the Resolution 196/96 CNS/MS, approved 
by the Ethics and Research Committee at Universidade Es-
tadual de Ciências da Saúde de Alagoas and all the subjects 
in the study gave their consent and received a copy of the 
informed consent.
The study subjects were oncologists recruited among 
those registered as members of the Brazilian Society of 
Clinical Oncology — SBOC. This particular professional 
group was chosen because they work directly with onco-
logical patients and routinely face the conflict of disclosing 
diagnosis, prognosis, treatment alternatives and further 
information relevant to this group of patients.
Initially, SBOC was contacted via e-mail and telephone 
in order to obtain the entity collaboration with the sur-
vey; SBOC was responsible for mailing its members the 
sealed envelope containing the documents for the survey. 
Thus, the investigators had no access to the oncologists’ 
addresses.
Next, all sealed and stamped envelopes to be addressed 
to the oncologists were mailed to the Society. The envelopes 
were individual and contained the following: a document 
with information about the technical aspects of the survey 
and instructions on how to complete the data collecting 
questionnaire; the form; the informed consent required 
so that the oncologist could obtain a full explanation on 
the survey through means of direct contact with the re-
sponsible investigator including telephone numbers and 
address to be used in case there were any doubts or when 
the respondent deemed necessary; two additional stamped 
envelopes addressed to SBOC and each one should be re-
turned with the questionnaire and the informed consent 
inside, respectively. After receiving the sealed envelopes 
mailed by the investigators, SBOC mailed them to the 
members after adding the address tags. All envelopes were 
previously stamped and thus there was no cost to either 
SBOC or the subjects.
The oncologists who agreed to participate in the survey 
returned the sealed envelopes with the informed consent 
and the completed questionnaire to SBOC. Later, the in-
vestigators received a parcel mailed by SBOC and contain-
ing all the sealed envelopes previously completed by the 
oncologists participating in the survey. As the envelopes 
were sealed, SBOC had no access to the identity of the on-
PAULA DANIELLE SANTA MARIA DE ALBUQUERQUE ET AL.
144 Rev Assoc Med Bras 2011; 57(2):142-150
41 to 50
years old 
51 years  
old
26%
29%
Figure 1 – Age of the oncologists participating in the survey.
39%
20 to 30
years old
31 to 40
years old
50%
25%
0%
Figure 2 – Who receives the information about the cancer 
diagnosis.
Family Patient and 
spouse
6% 3%
81%
10%
Patient Patient and 
family
cologists who were subjects in the survey. The Society had 
no access to the envelope contents in any step of the survey 
either.
This was a descriptive cross-sectional study with a quan-
titative approach by using the data collecting questionnaire 
with objective questions. The questionnaire initially ad-
dressed aspects related to the profile of the study subjects: 
age, gender, time from graduation, medical residency (yes 
or no), and Brazilian region where he/she has worked. 
The second part of the tool addressed the following topics: 
when the doctor informs the patient about the diagnosis; who 
the doctor informs; which aspects regarding the patient, 
the prognosis, the treatment, and the chance of cure, the 
oncologists take into account when providing the in-
formation; what is informed by the doctor; information 
properties; psychotherapy and palliative care. The data 
collecting questionnaire consisted of 27 (twenty-seven) 
questions; the first five questions addressed general data 
concerning the profile of the study subjects and, the re-
maining questions were specific about the topics previ-
ously mentioned. For this part of the questionnaire, the 
reply options were always the same: always, most of the 
time, half the time, seldom, never, I do not know and I do 
not want to reply.
Descriptive statistics with 95% confidence interval 
(95% CI)  calculation was used to calculate the data fre-
quency.
RESULTS
876 sealed envelopes were mailed to SBOC, correspond-
ing to the number of members of the society. Out of these, 
145 study subjects returned the questionnaire appropri-
ately completed and the informed consent signed, with a 
reply rate of 16.55%. Eight additional questionnaires were 
returned, but their addresses were not found. The col-
lected data were stored in a database software, in which 
there was no element that could identify the subjects, so 
ensuring total confidentiality for the volunteer participa-
tion. Upon copiling the data, the alternatives “always” and 
“most of the time” were summed up and turned into “most 
of the time”, since the dierence in meaning is very small. 
The same conduct was adopted for “seldom” and “never”, 
whose result was described as “seldom”.
The study oncologists were mostly males (60%), and 
the Brazilian region with the highest participation was the 
Southeast (40%). Figure1 shows the age groups. Among 
the subjects, 26% had less than 10 years of graduation, 
30% stated to have between 11 and 20 years of graduation, and 
26% reported between 21 and 30 years of occupation as 
physicians. The absolute majority of study subjects had a 
medical residency in clinical oncology (89%).
The first topic was related to whether the oncologists 
informed their patients about the cancer diagnosis, and 
the absolute majority (92%) answered yes, with only 5% 
giving a negative answer. When the question was whether 
they asked the patient what he/she desired to know about 
the disease, 85% of the oncologists reported they asked 
that question, and 12% said this approach did not occur 
often in their routine.
The other subject in the questionnaire concerned the 
moment when the doctor informed the patient about 
the diagnosis, and 89% of the volunteers answered the 
information was provided mostly at the first visit; how-
ever, 73% of the oncologists reported that, in most cases, 
the patient had already been aware of the disease. When 
the patient was not aware of the diagnosis, 61% of the 
volunteers stated they usually waited until the patient 
ask any question about the disease at the first visit, and 
43% of the physicians answered they did not have that 
conduct. The third topic addressed by the questionnaire 
was whom the oncologists informed the diagnosis to; the 
result is shown in Figure2.
The other part of the data collection tool was about 
the influence of certain aspects – patient characteristics, 
treatment, prognosis and chance of cure – on the process 
of informing about the disease. The results are shown in 
Table1.
Following, the content and coverage of the infor-
mation the oncologists provided to the patients were 
asked, and 81% of the physicians told they informed 
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about the diagnosis, the treatment, and the prognosis. 
When the prognosis is poor, 28% of the respondents report-
ed they informed only the family about the prognosis, and 
the family would decide whether or not they would 
tell the patient the real situation; 30% of the oncologists 
answered they informed the family and the patient to-
gether; and 7% informed only the patient, and he/she 
would decide whether to tell the family or not. Regarding 
the information about the patient’s lifetime expectancy, 
25% of the physicians answered they informed about it 
most of the time and 66% do not provide this informa-
tion often. The volunteers were asked about any physi-
cian-patient relationship problem arising from informing 
the patient about all the aspects of the disease, and the abso-
lute majority (91%) answered that they face trouble seldom-
ly or even never for appropriately informing the patient.
The information characteristics formed the fifth topic 
addressed in the data collecting questionnaire and 91% of 
the oncologists evaluated the information they provided to 
patients was complete. Regarding the use of medical terms 
when they informed the diagnosis, the prognosis and/or 
the treatment to patients, 70% of the volunteers stated that 
most of the time they used those terms, but 94% of the 
respondents answered they explained the medical term 
meanings to the patient.
Last, but not least, the topics psychotherapy indication 
in cancer patient care and palliative care were specifically 
addressed. Sixty per cent of the physicians participating 
in the survey referred their patients to psychotherapy. 
Twenty-three per cent of the respondents informed they 
seldom indicated it. Regarding palliative care, 89% of the 
oncologists told they informed patients about palliative 
care “most of the time” and only 7% of the doctors did not 
provide this guidance.
DISCUSSION
The number of subjects in the survey that returned the ques-
tionnaire appropriately completed was similar to the num-
ber of volunteers in other surveys using the same data col-
lection technique and requiring the return from the survey 
subjects. The reports in literature addressing this technique 
state the response obtained is around 21.5% of return11; 
thus, the number of subjects returning the data collecting 
questionnaire appropriately completed was as expected. In 
addition, it is important to stress that this data collection 
technique depends on the address of likely volunteers and a 
number of them changed their address, but did not update 
the information with the SBOC. Thus, the contact with the 
likely survey subjects was unintentionally lost.
Data collecting questionnaire (attached)
Part I – General data
1) Age
 _____years (  ) I do not know (  ) I do not want to answer
2) Gender
 (  ) Male ( ) Female (  ) I do not know (  ) I do not want to answer
3) Time from graduation in Medicine
 _____years (  ) I do not know (  ) I do not want to answer
4) Medical residency in Oncology?
 (  ) Yes (  ) No (  ) I do not know (  ) I do not want to answer
5) What is the Brazilian region where you work:
 (  ) Northern (  ) Southern (  ) Northeastern (  ) Southeastern (  ) Mid-Western
 (  ) I do not know (  ) I do not want to answer
Aspects related to the 
patient and considered by 
the physician upon providing 
the information
Influences 
most of  
the time
Seldom 
influences
Gender 5% 95%
Age 26% 65%
Socioeconomic status 22% 71%
Education level 37% 58%
Prognosis 27% 59%
Possibilities of treatment 19% 72%
Possibilities of cure 23% 68%
Table 1 – Patient characteristics, prognosis, treatment and 
chance of cure and how they influence the oncologists in 
the process of informing 
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Part II – Specic questionnaire
6) The information is provided at the first visit as a conduct of yours:
 (  ) Always (  ) Most of the time       (  ) I do not know      (  ) Half the time 
 (  ) I do not want to answer (  ) Seldom (  ) Never
7) As for the diagnosis, you let the patient know about his(her) disease at the first visit:
 (  ) Always (  ) Most of the time      (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
8) Do you ask the patient what he(she) wants to know about his(her) disease?
 (  ) Always (  ) Most of the time      (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
9) How often do you inform your patients about the cancer diagnosis?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
10) At the first visit, when the patient does not know the diagnosis, do you wait until the patient asks about 
the disease?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
11) As for the diagnosis, to whom do you provide the information?
 (  ) The patient (  ) The patient and the family (  ) The family (  ) The patient and spouse
 (  ) Spouse (  ) I do not provide any information (  ) I do not know (  ) I do not want to answer
12) Is the information to your patient changed depending on the patient’s gender?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
13) Is the information to your patient changed depending on the patient’s age?
(  ) Always (  ) Most of the time       (  ) I do not know        (  ) Half the time
(  ) I do not want to answer (  ) Seldom (  ) Never
14) Is the information to your patient changed depending on the patient’s socioeconomic status?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
15) Is the information to your patient changed depending on the patient’s education level?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
16) Is the information to your patient changed depending on the prognosis?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
17) Is the information to your patient changed depending on the possibilities of treatment?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
18) Is the information to your patient changed depending on the possibility of cure?
 (  ) Always (  ) Most of the time       (  ) I do not know (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
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The first part of the questionnaire regards the profile 
of the oncologists participating in the survey, and this 
profile was similar to that found for Brazilian physicians1, 
(Table 2), who are still predominantly males. The volun-
teers’ age groups, as well as the time from Medicine gradu-
ation, was in accordance with the time required for the 
oncologist’s education to be concluded – a two-year resi-
dency in internal medicine at a first step and later a three-
year specific residency in clinical oncology2. The clinical 
oncology residency requirement clearly demonstrates the 
obligation to fulfill that condition to practice this undeni-
ably important and complex specialty. The Southeastern 
region concentrates the highest number of physicians, 
compared with the other regions, with this fact warranting 
the result found (Table 2).
Regarding the act of informing the patient about his/
her disease, there is a consensus stating that this conduct 
is required from a physician. According to the article 34 of 
the Code of Medical Ethics – CEM12, the physician shall 
not leave the patient uniformed about the diagnosis, the 
19) Do you provide information about the diagnosis, the treatment and the prognosis?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
20) When the prognosis is poor, you:
 (  ) Tell it is serious, but it is not a critical illness.
 (  ) Inform the family, and the family decides whether or not to tell the patient everything.
 (  ) Inform the family and the patient together.
 (  ) Inform only the patient, and he(she) decides whether or not to tell the family.
 (  ) I do not want to answer.
21) Do you give information about the lifetime expectancy?:
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
22) Have you ever had any problem in the physician-patient relation after informing the patient about all the 
aspects of the illness?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
23) How do you evaluate the quality of the information you provide to your patient?
 (  ) It is always complete. (  ) It is complete most of the time.
 (  ) It is complete half the time. (  ) It is seldom complete.
 (  ) It is never complete. (  ) I do not know.        (  ) I do not want to answer.
24) Do you use medical terminology when you are going to inform the diagnosis, the prognosis and/or the 
treatment to your patient?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
25) Do you explain the medical terms to your patient?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
26) Do you refer your patients to psychotherapy?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
27) In the case of patients in a critical status, do you inform about available palliative care?
 (  ) Always (  ) Most of the time       (  ) I do not know       (  ) Half the time
 (  ) I do not want to answer (  ) Seldom (  ) Never
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prognosis, the risks and the treatment objectives, except 
when the direct communication might cause any harm; in 
this case, a legal representative must be notified. The re-
sults found are in accordance with the CEM principle, as 
well as with the premisse in which it is understood that 
telling the about the patient’s illness is shown to be an im-
portant and eective therapeutic tool. This conduct gener-
ates confidence and allows the patient to consciously ex-
ercise his/her autonomy13,14 and, as a result, the feeling of 
isolation is reduced, contributing to a mutual cooperation 
in the physician-patient relationship15. A survey developed 
in Japan demonstrated that most patients prefer to receive 
all the information about their disease16. However, even in 
the face of this statement, the premisse does not result in 
universal informing practice, including even diseases as 
serious as cancer17.
Transmitting bad news, as in the case of a cancer diag-
nosis, is an exceedingly complex situation and preparation 
and sensitivity are required to face it. Disclosing the diagno-
sis or not is until the present day an ethical conflict often ex-
perienced by the health team3. The moment to provide the 
information should be chosen by the physician from the pa-
tient’s psychological condition. This moment requires sen-
sitivity and must be carefully developed or it will turn out 
to be a cold report, in which the patient is not comfortable 
to ask all the questions he/she might have2,3,18. In cases the 
patients have already been informed about the diagnosis, it 
should be the responsibility of the oncologist to provide fur-
ther information on the disease, as well as the possibilities of 
treatment, prognosis and other kinds of care18.
Even experienced practitioners may have concerns 
about the best moment to inform the patient on the diag-
nosis. Most volunteers admitted providing this informa-
tion at the first visit; however, the report that the patient 
is commonly aware of the diagnosis when he/she goes to 
the oncologist is frequent. This occurs because the patient 
sees first a doctor from another specialty and then, when 
a cancer is diagnosed, the patient is referred to an oncolo-
gist. Actually, there is no consensus about the best moment 
to provide the information on the disease; however, it is a 
consensus on always telling the truth to the patient3,19.
Apart from the setting described above, in cases when 
the patients are not aware of the diagnosis, many oncolo-
gists admitted they wait until the patient asks questions 
about the disease in the first visit. By so doing, the physi-
cian’s caution and the patient’s time are considered, with 
the information becoming something not mandatory at 
first20. Another option is to ask the patient what he/she 
wants to know about his/her illness, as receiving the infor-
mation is a right, not an obligation. The patient should be 
asked about his/her desire to receive the information and, 
in case of a negative answer, he/she would tell to whom the 
information should be provided19.
The oncologists usually provide the information to the 
patient and the family together, probably because many 
patients come to see them accompanied by a family mem-
ber. Such a situation could lead the physician to consider 
the patient implicitly authorizes the physician to provide 
all information in front of the companion21. However, the 
physician should always ask the patient if he/she can speak 
openly in the presence of the companion, as the confiden-
tiality and privacy principles22 require such a precaution 
and attention; furthermore, some patients do not want 
other people to be aware of their condition, even fam-
ily members. Other patients let the family make all deci-
sions, even if they are fully capable23. The patient and the 
family should be considered as having dynamics to cope 
with problems, but, in a setting like this, the system might 
be corrupted24. The “cancer journey”, the stages through 
which the patients and their caretakers go, may bring con-
sequences for all people involved25 and, before the new 
facts, the family relation could undergo changes.
Another result regards the aspects the oncologists take 
into account upon informing the patient, and the absolute 
majority of respondents informed they had never given 
importance to the patient’s gender, as the influence comes 
from the quality of autonomy the patient shows. In some 
special situations, the oncologists take into account the 
patient’s socioeconomic status before informing him/her; 
however, what is to be considered is the education level, 
as it either can or cannot have a causal connection with 
the socioeconomic status and, as a consequence, with the 
patient’s understanding the information that will be pro-
vided3.
Age is an often considered factor, as for too young or 
elderly patients, physicians, as well as the family usually 
have a patronizing attitude. In a study conducted with can-
cer patients about the diagnosis and prognosis compre-
hension, 79.3% of the subjects fully understood it was a 
malignancy; when this result was associated with age, the 
patients were found to be <70 years old26. However, it is 
important to stress the elderly and the too young patients 
will only have a reduced autonomy quality when their cog-
nitive function is aected1; otherwise, they must be con-
sidered entirely autonomous.
Region Registered physicians Practitioners
Northern 25,415 14,667
Northeastern 85,399 58,763
Mid-western 43,799 26,328
Southern 78,004 53,707
Southeastern 294,983 201,054
Table 2 – Total of physicians registered and actively 
practicing in Brazil 
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The prognosis is also considered by oncologists, as in 
more severe cases, the physician will be prone towards 
patronizing, considering it di cult to inform the patient 
and demonstrating an old prejudice regarding oncologi-
cal patients – the idea that they would not like to know 
about their illness2. Finally, the possibility of cure makes 
the situation more comfortable if possible, but when there 
is not such a perspective, the conflict about informing or 
not is created. However, even patients with a progressive 
and incurable disease need to understand what is occur-
ring with them and their body; they need to participate in 
the decision-making processes on how they are going to 
live their remaining days2. A number of oncologists admit 
informing the diagnosis in critical disease cases only in 
the following situations: the patient asks directly about the 
situation; the patient is observed to be emotionally stable; 
the treatment is not eective; when there are important 
decisions to be made about the treatment4.
As for the content and coverage of the information the 
oncologists provided to patients, the result showed the vol-
unteer practice was in accordance with the ethical prin-
ciples adopted by the Code of Medical Ethics12 thus stimu-
lating the patient to exercise his/her autonomy. However, 
in the case of a poor prognosis, it was evident the conduct 
can change, as most oncologists told they did not inform 
the severity to the patient if he/she had no companion. 
When the severity was informed, they did it in the pres-
ence of a family member and, in other cases, they would 
tell the family members, who decided what to do. On this 
issue, a number of authors admit that informing the diag-
nosis is dierent from telling the prognosis, as the same 
patient who desires to receive all the information about the 
diagnosis might not desire to be informed about the prog-
nosis14. Therefore, considering the situation is required, 
since considering that the non-communication as a con-
duct to “preserve” the patient is underestimate the reality 
of facts. The real objective if often the physician protection, 
as he/she find him/herself helpless before his/her limita-
tions “to cure”, insecure at instructing and unprepared to 
“care”2. This phenomenon is a reflection of the physicians’ 
background in the graduation course, as they are prepared 
to save lives and the opportunities to discuss themes re-
garding death are few, even death coming after an illness 
natural process pertaining to human condition2.
The oncologists participating in the survey evaluated 
the quality of the information they provided to their pa-
tients was always or almost always complete; however, 
these same practitioners told they not always informed 
everything to the patient. In this case, an incongruity is re-
alized among the results, and the oncologists’ evaluation 
might be mistaken, as not providing all the information 
to patients should be an exception. A study conducted 
with adolescents surviving cancer reported these patients 
were aware of the disease, participated in the decisions 
on treatment, including the topic end of life, made their 
decisions autonomously and excluded their parents from 
the process27. Informing the patient does not assume the 
physicians will be in trouble; most of them never or just 
a few times had to go through any conflicting situation 
from appropriately informing the patient.
Continuing with quality of information, many on-
cologists admit the use of technical terms, but most of 
them explain the medical terminology meaning to their 
patients, thus avoiding communication interpretation 
problems. A survey showed 39% of physicians still  does 
not succeed in explaining the problem clearly and com-
prehensively to their patients; in 58% of visits, the level 
of the patient’s understanding on their diagnosis was not 
established3. Medical terminology pertains to the prac-
tice and the physician is responsible for explaining, in a 
clear and reachable language, all aspects of the disease 
so that the patient feels comfortable and asks the doctor 
what he/she wants to know and what is not completely 
understood.
Referring the patient to receive psychological support 
is a practice that should be used more often to assist the 
patient and the physician to cope with those situations, 
notably in cases with a poor prognosis. Oncological pa-
tients need to be attended by a multidisciplinary team, as 
they especially want psychological support, often needed 
by the families as well. Referring patients with cancer to 
psychological therapy will give them the appropriate sup-
port to face the situation and fully exercise their autonomy. 
Therapy targets are also the patient learning to face and 
managing positive and negative events satisfactorily28.
The last topic discussed regards palliative care5, since 
in many cases patients with cancer will require this kind 
of care, being the oncologist responsible for informing 
the patients on their availability when they are the best 
option. A number of studies demonstrate physicians do 
not know how to address end of life themes when deal-
ing with patients and they likely associate this conduct 
with a neglect of the correct prescription to relieve the 
symptons30. In case there are no further possibilities of 
oncological treatment, sincerity does not mean telling 
the patient there is nothing else to be done, as palliative 
care should not be underappreciated21. Palliative care will 
ensure quality of life to patients and will supply the fam-
ily with conditions to cope with the situation in the best 
way possible, consequently meeting the patient’s needs.
CONCLUSION
In view of the results presented, we can conclude the study 
population noticeably has the concern to inform the pa-
tient, fitting the patient’s profile and characteristics. The 
oncologists are noticed trying to address the information 
and providing the patients with that they are entitled to 
– the truth; nevertheless, they often resort to the family 
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for assistance in providing the information. The physician 
is responsible for providing all explanations to favor the 
patient’s full exercise of autonomy, as information is the 
cornerstone for an autonomous decision making.
Palliative care experience is also recommended for 
most patients. Another important issue in the oncologist’s 
conduct – referring the patients to psychotherapy – is not 
as valued as is should, even though an interdisciplinary 
team work is mandatory in the care of patients with cancer.
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